Literature DB >> 30773218

Inclusion of non-target antigen in vaccination favors generation of OVA specific CD4 memory T cells.

Aditi MohanKrishnan1, Hardik Patel1, Vishakha Bhurani1, Rajesh Parmar1, Naveen Yadav1, Niyam Dave1, Sonal Rana1, Somnath Gupta1, Jagdish Madariya1, Prerak Vyas1, Sarat Kumar Dalai2.   

Abstract

Inducing long-lived memory T cells by sub-unit vaccines has been a challenge. Subunit vaccines containing single immunogenic target antigen from a given pathogen have been designed with the presumption of mimicking the condition associated with natural infection, but fail to induce quality memory responses. In this study, we have included non-target antigens with vaccine candidate, OVA, in the inoculum containing TLR ligands to suffice the minimal condition of pathogen to provoke immune response. We found that inclusion of immunogenic HEL (hen egg lysozyme) or poorly immunogenic MBP (Myelin Basic protein) non-target antigen enhances the OVA specific CD4 T cell responses. Interestingly, poorly immunogenic MBP was found to strongly favor the generation of OVA specific memory CD4 T cells. MBP not only improves magnitude of T cell response but also promotes the T cells to undergo higher cycles of division, one of the characteristic of central memory T cells. Inclusion of MBP with vaccine targets was also found to promote multiple cytokine producing CD4 T cells. We also found that challenge of host with non-target antigen MBP favors generation of central Memory T cells.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Goals of vaccination; Memory CD4 T cells; Natural infection; Vaccine; non-target Ag

Mesh:

Substances:

Year:  2018        PMID: 30773218     DOI: 10.1016/j.cellimm.2018.11.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  1 in total

1.  Traceable metallic antigen release for enhanced cancer immunotherapy.

Authors:  Fangfang Lv; Yan Jin; Xiaochen Feng; Miao Fan; Cui Ren; Xinyue Dai; Jinchao Zhang; Zhenhua Li; Yi Jin; Huifang Liu
Journal:  J Nanopart Res       Date:  2021-06-14       Impact factor: 2.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.